Versant Vantage Ii, L.p. - Net Worth and Insider Trading

Versant Vantage Ii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Versant Vantage Ii, L.p. owns 4 companies in total, including Tempest Therapeutics Inc (TPST) , Graphite Bio Inc (GRPH) , and Century Therapeutics Inc (IPSC) among others .

Click here to see the complete history of Versant Vantage Ii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Versant Vantage Ii, L.p.

Ticker Comapny Transaction Date Type of Owner
TPST Tempest Therapeutics Inc 2022-04-29 10 percent owner
GRPH Graphite Bio Inc 2021-06-24 10 percent owner
IPSC Century Therapeutics Inc 2021-12-23 10 percent owner
LIMIT LIMIT 2023-07-20 10 percent owner

Versant Vantage Ii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Versant Vantage Ii, L.p. Ownership Network

Ownership Network List of Versant Vantage Ii, L.p.

No Data

Ownership Network Relation of Versant Vantage Ii, L.p.

Insider Network Chart

Versant Vantage Ii, L.p. Owned Company Details

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Versant Vantage Ii, L.p. is the 10 percent owner of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Chief Medical Officer Samuel Whiting .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

Over the past 18 months, Versant Vantage Ii, L.p. made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .

In summary, during the past 3 months, insiders sold 787,999 shares of Tempest Therapeutics Inc (TPST) in total and bought 39,672 shares, with a net sale of 748,327 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tempest Therapeutics Inc Insider Transactions

No Available Data

Versant Vantage Ii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Versant Vantage Ii, L.p.. You might contact Versant Vantage Ii, L.p. via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.

Discussions on Versant Vantage Ii, L.p.

No discussions yet.